RPM uses wearables, patches, implantables, and connected peripherals to collect vitals, biometrics, and disease-specific signals, transmitting data to clinicians or platforms for monitoring and intervention. Some wearables are general wellness products outside FDA oversight, while those that diagnose or monitor disease are regulated devices. In the US, Medicare pays for RPM through specific CPT codes that require device supply and data review time thresholds. Cybersecurity, data accuracy and patient adherence are the main practical challenges.

Why it matters

Medicare RPM and RTM CPT codes have catalyzed adoption. Data quality, alert fatigue, and integration with EHRs remain core challenges.

Common pitfalls

•A common pitfall is misunderstanding the regulatory classification of a wearable or RPM device, leading to inadequate premarket submissions or non-compliance.
•Ignoring data privacy regulations like HIPAA in the US or GDPR in the EU for collected patient data can result in significant legal and financial penalties.
•Failing to implement robust cybersecurity controls throughout the device lifecycle can expose patients to risks and lead to regulatory enforcement actions.
•Underestimating the importance of human factors engineering in device design can lead to user errors and compromised patient safety.
•Neglecting to establish a comprehensive postmarket surveillance system can result in delayed identification of device-related issues and non-compliance with regulatory requirements.

Sources

AdvaMed - Industry Reports · AdvaMed
MedTech Europe - Facts & Figures · MedTech Europe
MedTech Dive · MedTech Dive
Sensor-based digital health technology · U.S. Food and Drug Administration (FDA)

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.